A Direct Droplet Digital PCR Method for <i>E. coli</i> Host Residual DNA Quantification
- 1 Merck & Co., Inc., Kenilworth, New Jersey, USA
- 2 Merck & Co., Inc., Kenilworth, New Jersey, USA
Abstract
Injectable drugs manufactured in E. coli must be tested for host residual DNA (hr DNA) impurity in ensuring drug purity and safety. Because of low allowable hr DNA as impurity, highly sensitive methods are needed. Droplet digital PCR (ddPCR) is a new method where the reaction is partitioned into about 20,000 nanoliter-sized droplets and each droplet acts as individual PCR reaction. After completion of end-point PCR, droplets are analyzed for fluorescence and categorized as positive or negative and DNA quantified using Poisson statistics. Here we describe development of a direct E. coli hr DNA dd PCR method where the drug is directly added to the ddPCR reaction. We show that the ddPCR method has acceptable precision and high accuracy, works with different biologic drugs, and compared to qPCR shows higher tolerance of drug matrices. The method does not require DNA extraction or standard curves for quantification of hr DNA in unknown samples.
- Sanchez-Garcia, L., Martin, L., Mangues, R., Ferrer-Miralles, N., Vazquez, E. and Villaverde, A. (2016) Recombinant Pharmaceuticals from Microbial Cells: A 2015 Update. Microbial Cell Factories, 15, 33. https://doi.org/10.1186/s12934-016-0437-3
- Baeshen, N., Baeshen, M., Sheikh, A., Bora, R., Ahmed, M., Ramadan, H., Saini, K. and Redwan, E. (2014) Cell Factories for Insulin Production. Microbial Cell Factories, 13, 141. https://doi.org/10.1186/s12934-014-0141-0
- Baeshen, M., Al-Hejin, A., Bora, R., Ahmed, M., Ramadan, H., Saini, K., Baeshen, N. and Redwan, E. (2015) Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives. Journal of Microbiology and Biotechnology, 25, 953-962. https://doi.org/10.4014/jmb.1412.12079
- Kamionka, M. (2011) Engineering of Therapeutic Proteins Production in Escherichia coli. Current Pharmaceutical Biotechnology, 12, 268-274. https://doi.org/10.2174/138920111794295693
- World Health Organization (WHO) (1997) WHO Expert Committee on Biological Standardization. Highlights of the 46th Meeting, October 1996. The Weekly Epidemiological Record (WER), 72, 141-145.
- Wang, X., Moran, D., Wang, G. and Mozier, N. (2012) Residual DNA Analysis in Biologics Development: Review of Measurement and Quantitation Technologies and Future Directions. Biotechnology and Bioengineering, 109, 307-317. https://doi.org/10.1002/bit.23343
- Mamnoon, B., Farivar, T., Kamyab, A., Ilghari, D., Khamesipour, A. and Arzenani, M. (2016) Quality Control of Widely Used Therapeutic Recombinant Proteins by Novel Real-Time PCR Approach. Iranian Biomedical Journal, 20, 56-62.
- Hussain, M. (2015) A Direct qPCR Method for Residual DNA Quantification in Monoclonal Antibody Drugs Produced in CHO Cells. Journal of Pharmaceutical and Biomedical Analysis, 115, 603-606. https://doi.org/10.1016/j.jpba.2015.03.005
- Hussain, M., Fantuzzo, R., Mercorelli, S. and Cullen, C. (2016) A Direct Droplet Digital PCR Method for Quantification of Residual DNA in Protein Drugs Produced in Yeast Cells. Journal of Pharmaceutical and Biomedical Analysis, 123, 128-131. https://doi.org/10.1016/j.jpba.2016.01.050
- Trypsteen, W., Vynck, M., De Neve, J., Bonczkowski, P., Kiselinova, M., Malatinkova, E., Vervisch, K., Thas, O., Vandekerckhove, L. and De Spiegelaere, W. (2015) ddpcRquant: Threshold Determination for Single Channel Droplet Digital PCR Experiments. Analytical and Bioanalytical Chemistry, 407, 5827-5834. https://doi.org/10.1007/s00216-015-8773-4